tiprankstipranks
Trending News
More News >
Giant Biogene Holding Co. Ltd. (HK:2367)
:2367
Hong Kong Market

Giant Biogene Holding Co. Ltd. (2367) Stock Forecast & Price Target

Compare
10 Followers
See the Price Targets and Ratings of:

2367 Analyst Ratings

Strong Buy
13Ratings
Strong Buy
12 Buy
1 Hold
0 Sell
Based on 13 analysts giving stock ratings to
Giant
Biogene Holding Co. Ltd.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2367 Stock 12 Month Forecast

Average Price Target

HK$48.65
▲(52.41% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Giant Biogene Holding Co. Ltd. in the last 3 months. The average price target is HK$48.65 with a high forecast of HK$61.00 and a low forecast of HK$39.50. The average price target represents a 52.41% change from the last price of HK$31.92.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"31":"HK$31","43":"HK$43","55":"HK$55","67":"HK$67","79":"HK$79"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":61,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$61.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":48.65,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$48.65</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":39.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$39.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[31,43,55,67,79],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.66,34.839999999999996,37.019999999999996,39.199999999999996,41.379999999999995,43.559999999999995,45.739999999999995,47.92,50.099999999999994,52.28,54.459999999999994,56.64,58.82,{"y":61,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.66,33.88999999999999,35.12,36.349999999999994,37.58,38.809999999999995,40.04,41.269999999999996,42.5,43.73,44.96,46.19,47.42,{"y":48.65,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.66,33.18615384615384,33.71230769230769,34.238461538461536,34.76461538461538,35.29076923076923,35.816923076923075,36.34307692307692,36.86923076923077,37.395384615384614,37.92153846153846,38.44769230769231,38.973846153846154,{"y":39.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":55.57,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.19,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.62,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.2,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.71,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.7,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.55,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.85,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.58,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.28,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.66,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetHK$61.00Average Price TargetHK$48.65Lowest Price TargetHK$39.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CICC Analyst forecast on HK:2367
Unknown Analyst
CICC
Not Ranked
CICC
HK$56
Buy
75.44%
Upside
Reiterated
01/16/26
CICC Reaffirms Their Buy Rating on Giant Biogene Holding Co. Ltd. (2367)
Guotai Haitong Analyst forecast on HK:2367
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$43.6
Buy
36.59%
Upside
Reiterated
01/14/26
Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Guotai Haitong
Goldman Sachs Analyst forecast on HK:2367
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
HK$71HK$46
Buy
44.11%
Upside
Reiterated
01/08/26
Giant Biogene Holding Co. Ltd. (2367) Gets a Buy from Goldman Sachs
Morgan Stanley Analyst forecast on HK:2367
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
HK$78HK$42
Buy
31.58%
Upside
Reiterated
12/16/25
Morgan Stanley Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)
UBS
HK$79.5HK$39.5
Hold
23.75%
Upside
Downgraded
12/10/25
UBS Sticks to Its Hold Rating for Giant Biogene Holding Co. Ltd. (2367)
Citic Securities Analyst forecast on HK:2367
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$55HK$44
Buy
37.84%
Upside
Reiterated
12/10/25
Citic Securities Reaffirms Their Buy Rating on Giant Biogene Holding Co. Ltd. (2367)
HSBC Analyst forecast on HK:2367
Unknown Analyst
HSBC
Not Ranked
HSBC
HK$69.3HK$46.4
Buy
45.36%
Upside
Reiterated
12/05/25
HSBC Sticks to Their Buy Rating for Giant Biogene Holding Co. Ltd. (2367)
CMB International Securities Analyst forecast on HK:2367
CMB International Securities
CMB International Securities
HK$58.35HK$53.89
Buy
68.83%
Upside
Reiterated
12/03/25
CMB International Securities Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)
Citi
HK$55.4HK$44.6
Buy
39.72%
Upside
Reiterated
12/03/25
Citi Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)
Jefferies Analyst forecast on HK:2367
Jefferies
Jefferies
HK$55
Buy
72.31%
Upside
Reiterated
12/03/25
Jefferies Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)
Macquarie Analyst forecast on HK:2367
Macquarie
Macquarie
HK$61
Buy
91.10%
Upside
Reiterated
12/03/25
Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Macquarie
Bank of America Securities Analyst forecast on HK:2367
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
HK$68.3HK$55.5
Buy
73.87%
Upside
Reiterated
12/02/25
Bank of America Securities Keeps Their Buy Rating on Giant Biogene Holding Co. Ltd. (2367)
CSC Financial Analyst forecast on HK:2367
Unknown Analyst
CSC Financial
Not Ranked
CSC Financial
HK$45
Buy
40.98%
Upside
Reiterated
12/02/25
Bernstein
HK$70
Buy
119.30%
Upside
Reiterated
11/12/25
Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Bernstein
Huatai Securities Analyst forecast on HK:2367
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$85
Buy
166.29%
Upside
Reiterated
10/24/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CICC Analyst forecast on HK:2367
Unknown Analyst
CICC
Not Ranked
CICC
HK$56
Buy
75.44%
Upside
Reiterated
01/16/26
CICC Reaffirms Their Buy Rating on Giant Biogene Holding Co. Ltd. (2367)
Guotai Haitong Analyst forecast on HK:2367
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$43.6
Buy
36.59%
Upside
Reiterated
01/14/26
Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Guotai Haitong
Goldman Sachs Analyst forecast on HK:2367
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
HK$71HK$46
Buy
44.11%
Upside
Reiterated
01/08/26
Giant Biogene Holding Co. Ltd. (2367) Gets a Buy from Goldman Sachs
Morgan Stanley Analyst forecast on HK:2367
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
HK$78HK$42
Buy
31.58%
Upside
Reiterated
12/16/25
Morgan Stanley Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)
UBS
HK$79.5HK$39.5
Hold
23.75%
Upside
Downgraded
12/10/25
UBS Sticks to Its Hold Rating for Giant Biogene Holding Co. Ltd. (2367)
Citic Securities Analyst forecast on HK:2367
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$55HK$44
Buy
37.84%
Upside
Reiterated
12/10/25
Citic Securities Reaffirms Their Buy Rating on Giant Biogene Holding Co. Ltd. (2367)
HSBC Analyst forecast on HK:2367
Unknown Analyst
HSBC
Not Ranked
HSBC
HK$69.3HK$46.4
Buy
45.36%
Upside
Reiterated
12/05/25
HSBC Sticks to Their Buy Rating for Giant Biogene Holding Co. Ltd. (2367)
CMB International Securities Analyst forecast on HK:2367
CMB International Securities
CMB International Securities
HK$58.35HK$53.89
Buy
68.83%
Upside
Reiterated
12/03/25
CMB International Securities Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)
Citi
HK$55.4HK$44.6
Buy
39.72%
Upside
Reiterated
12/03/25
Citi Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)
Jefferies Analyst forecast on HK:2367
Jefferies
Jefferies
HK$55
Buy
72.31%
Upside
Reiterated
12/03/25
Jefferies Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)
Macquarie Analyst forecast on HK:2367
Macquarie
Macquarie
HK$61
Buy
91.10%
Upside
Reiterated
12/03/25
Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Macquarie
Bank of America Securities Analyst forecast on HK:2367
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
HK$68.3HK$55.5
Buy
73.87%
Upside
Reiterated
12/02/25
Bank of America Securities Keeps Their Buy Rating on Giant Biogene Holding Co. Ltd. (2367)
CSC Financial Analyst forecast on HK:2367
Unknown Analyst
CSC Financial
Not Ranked
CSC Financial
HK$45
Buy
40.98%
Upside
Reiterated
12/02/25
Bernstein
HK$70
Buy
119.30%
Upside
Reiterated
11/12/25
Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Bernstein
Huatai Securities Analyst forecast on HK:2367
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$85
Buy
166.29%
Upside
Reiterated
10/24/25
Stocks with the Highest Top Analyst Consensus in the Consumer Defensive Sector
Find stocks in the Consumer Defensive sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Giant Biogene Holding Co. Ltd.

3 Months
xxx
Success Rate
4/9 ratings generated profit
44%
Average Return
-1.06%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of -1.06% per trade.
1 Year
Success Rate
1/4 ratings generated profit
25%
Average Return
-3.85%
upgraded a buy rating 27 days ago
Copying xAi Consumer Defensive HK's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -3.85% per trade.
2 Years
xxx
Success Rate
1/4 ratings generated profit
25%
Average Return
-3.85%
upgraded a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -3.85% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2367 Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
7
6
9
5
4
Buy
25
14
17
17
21
Hold
21
11
13
13
21
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
53
31
39
35
46
In the current month, 2367 has received 25 Buy Ratings, 21 Hold Ratings, and 0 Sell Ratings. 2367 average Analyst price target in the past 3 months is 48.65.
Each month's total comprises the sum of three months' worth of ratings.

2367 Financial Forecast

2367 Earnings Forecast

Next quarter’s earnings estimate for 2367 is HK$0.77 with a range of HK$0.77 to HK$0.77. The previous quarter’s EPS was HK$1.26. 2367 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.98% of the time in the same period. In the last calendar year 2367 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 2367 is HK$0.77 with a range of HK$0.77 to HK$0.77. The previous quarter’s EPS was HK$1.26. 2367 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.98% of the time in the same period. In the last calendar year 2367 has Performed in-line its overall industry.

2367 Sales Forecast

Next quarter’s sales forecast for 2367 is HK$2.64B with a range of HK$2.64B to HK$2.64B. The previous quarter’s sales results were HK$3.34B. 2367 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 52.41% of the time in the same period. In the last calendar year 2367 has Performed in-line its overall industry.
Next quarter’s sales forecast for 2367 is HK$2.64B with a range of HK$2.64B to HK$2.64B. The previous quarter’s sales results were HK$3.34B. 2367 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 52.41% of the time in the same period. In the last calendar year 2367 has Performed in-line its overall industry.

2367 Stock Forecast FAQ

What is HK:2367’s average 12-month price target, according to analysts?
Based on analyst ratings, Giant Biogene Holding Co. Ltd.’s 12-month average price target is 48.65.
    What is HK:2367’s upside potential, based on the analysts’ average price target?
    Giant Biogene Holding Co. Ltd. has 52.41% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Giant Biogene Holding Co. Ltd. a Buy, Sell or Hold?
          Giant Biogene Holding Co. Ltd. has a consensus rating of Strong Buy, which is based on 12 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Giant Biogene Holding Co. Ltd.’s share price target?
            The average share price target for Giant Biogene Holding Co. Ltd. is 48.65. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$61.00 ,and the lowest forecast is HK$39.50. The average share price target represents 52.41% Increase from the current price of HK$31.92.
              What do analysts say about Giant Biogene Holding Co. Ltd.?
              Giant Biogene Holding Co. Ltd.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of Giant Biogene Holding Co. Ltd.?
                To buy shares of HK:2367, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.